Video Experimental Relacionado
Updated: Nov 8, 2025
04:45
Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
Published on: May 5, 2022
2.7K
Implicación cardíaca del SARS-CoV-2 en jóvenes atletas competitivos
Nathaniel Moulson1,2, Bradley J Petek1,2, Jonathan A Drezner3
1Division of Cardiology (N.M., B.J.P., A.L.B.), Massachusetts General Hospital, Boston.
Circulation
|April 19, 2021
Resumen
La participación cardíaca por COVID-19 es poco común en atletas jóvenes, con un bajo riesgo de eventos adversos. La resonancia magnética cardíaca es más efectiva cuando está clínicamente indicada que para el cribado primario.
Área de la Ciencia:
- Cardiología
- Enfermedades infecciosas
- Medicina del deporte
Sus antecedentes:
- La participación cardíaca es frecuente en pacientes con COVID-19 graves.
- La prevalencia y las implicaciones de la afectación cardíaca en atletas jóvenes no están bien definidas.
Objetivo del estudio:
- Para determinar la prevalencia de la participación cardíaca en atletas jóvenes de competición después de la infección por SARS-CoV-2.
- Evaluar las implicaciones clínicas y el rendimiento diagnóstico de las pruebas cardíacas en esta población.
Principales métodos:
- Estudio prospectivo de cohorte de observación multicéntrica de atletas universitarios en los Estados Unidos.
- Evaluación cardíaca que incluye ECG, troponina, ecocardiografía y resonancia magnética cardíaca para los atletas que dan positivo para SARS-CoV-2.
- Análisis de la prevalencia, predictores y eventos adversos cardiovasculares.
Principales resultados:
- Entre los 3018 atletas infectados, el 0,7% mostró una implicación cardíaca definitiva, probable o posible.
- La resonancia magnética cardíaca clínicamente indicada tuvo un rendimiento diagnóstico más alto (12,6%) que la resonancia magnética de cribado primario (3,0%).
- Los síntomas cardiopulmonares y las pruebas cardíacas iniciales anormales predijeron la implicación; los eventos cardíacos adversos fueron raros (0, 03%).
Conclusiones:
- La infección por SARS-CoV-2 en jóvenes atletas competitivos se asocia con una baja prevalencia de afectación cardíaca.
- El seguimiento a corto plazo revela un bajo riesgo de eventos cardiovasculares clínicos.
Palabras clave:
El COVID-19En el caso del SARS-CoV-2los atletasMiocarditis en el corazónRegreso al deporteMás Videos Relacionados
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.0K
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
7.5K
Videos de Conceptos Relacionados
01:29Pathophysiology of Cardiac Performance
1.0K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.0K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
166
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
166
01:27Myocarditis II: Clinical Features and Diagnostic Tests
76
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
76
01:21Myocarditis I: Introduction
135
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
135
01:30Cardiomyopathy II: Dilated Cardiomyopathy
121
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
121
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
119
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
119